• Corpus ID: 195739040

Perinatal Hypoxic-Ischemic Brain Injury : Detection & Intervention

@inproceedings{2017PerinatalHB,
  title={Perinatal Hypoxic-Ischemic Brain Injury : Detection \& Intervention},
  author={},
  year={2017}
}
  • Published 2017
  • Medicine

Figures and Tables from this paper

References

SHOWING 1-10 OF 244 REFERENCES

Molecular Targets of Cannabidiol in Neurological Disorders

CBD was found to act upon a number of targets that are linked to neurological therapeutics but that its actions were not consistent with modulation of such targets that would derive a therapeutically beneficial outcome.

Na+/H+ Exchangers and Intracellular pH in Perinatal Brain Injury

Experimental animal models of hypoxia–ischemia show that NHE inhibitors are neuroprotective and a rapid recovery of brain intracellular pH has been termed pH paradox as, rather than causing cells to recover, this rapid return to normal and overshoot to alkaline values is deleterious to cell survival.

Mitochondrial Dysfunction and NAD+ Metabolism Alterations in the Pathophysiology of Acute Brain Injury

The role of MPT in acute brain injury and its role in mitochondrial NAD+ metabolism, and their role in individual NAD+ glycohydrolases, both cytosolic and mitochondrial, are discussed.

Cerebral inflammation and mobilization of the peripheral immune system following global hypoxia-ischemia in preterm sheep

Evidence is provided that global HI in preterm ovine fetuses resulted in profound cerebral inflammation and mobilization of the peripheral innate immune system, which was paralleled by marked injury and functional loss of the preterm brain.

Good guy or bad guy: the opposing roles of microRNA 125b in cancer

The current knowledge of miR-125b and its relevant targets in different tumor types are summarized and several hypotheses for the opposing roles are offered, suggesting that misregulation by miR -125b depends on the levels of target gene expression.

Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins

It is indicated that 2.5 μM of CBD, the higher dose tolerated by differentiated SH-SY5Y neuronal cells, does not provide neuroprotection for terminally differentiated cells and shows, for the first time, that exposure of CBD during neuronal differentiation could sensitize immature cells to future challenges with neurotoxins.

Cannabidiol Normalizes Caspase 3, Synaptophysin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection

The results suggest that iron affects mitochondrial dynamics, possibly trigging synaptic loss and apoptotic cell death and indicate that CBD should be considered as a potential molecule with memory-rescuing and neuroprotective properties to be used in the treatment of cognitive deficits observed in neurodegenerative disorders.

microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases

A comprehensive overview of the existing knowledge of microRNAs in neurodegeneration is presented and a perspective of the applicability of micro RNAs as a basis for future therapeutic intervention strategies is provided.

Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression.

The results of the present study confirm in vivo anti-inflammatory actions of CBD, emphasizing the importance of this compound as a novel promising pharmacological tool capable of attenuating Abeta evoked neuroinflammatory responses.
...